O-024mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109)
Geissler, M, Klingler, T, Riera-Knorrenschield, J, Tannapfel, A, Seufferlein, T, Held, S, Florschütz, A, Kanzler, S, Heinemann, V, Reinacher-Schick, A, Martens, UVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy149.023
Date:
June, 2018
File:
PDF, 46 KB
english, 2018